دورية أكاديمية
Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States
| العنوان: | Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States |
|---|---|
| المؤلفون: | W. Frank Peacock MD, FACEP, FACC, FESC, James M. Crawford MD, PhD, Yen-Wen (Cindy) Chen PhD, Veronica Ashton MPH, Alicia K. Campbell PharmD, Dejan Milentijevic PhD, MBA, Alex C. Spyropoulos MD, FACP, FCCP, FRCPC |
| المصدر: | Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022) |
| بيانات النشر: | SAGE Publishing, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Diseases of the circulatory (Cardiovascular) system |
| مصطلحات موضوعية: | Diseases of the circulatory (Cardiovascular) system, RC666-701 |
| الوصف: | Limited data are available on thromboembolic events (TEEs) and mortality in outpatients with coronavirus disease 2019 (COVID-19). This retrospective, observational cohort study identified non-hospitalized COVID-19 outpatients (01/21/2020-01/07/2021) using de-identified Optum ® COVID-19 Electronic Health Records data. Patient characteristics, occurrence of TEEs, all-cause mortality, and anticoagulant or thrombolytic medication use were evaluated. Of 1,246,067 patients with COVID-19 diagnosis, 141 471 met entry criteria. Mean (standard deviation [SD]) age was 46.1 (17.2) years, 56.8% were female, 72.9% Caucasian, 11.2% African American, and 11.1% Hispanic. Comorbidity burden was low (mean [SD] Quan-Charlson comorbidity index score of 0.43 [1.10]); however, of those with body mass index data, half were obese. During the follow-up period, a TEE occurred in 1.4%, with the proportion of patients with ischemic stroke, myocardial infarction, deep vein thrombosis, and pulmonary embolism being similar (approximately 0.4% each). All-cause mortality was 0.7%. Medications included corticosteroids (13.7%), anticoagulants (4.9%), and antiplatelets (2.9%). Overall, in this large cohort analysis, certain demographic and clinical characteristics of patients who experienced TEEs were identified and may help guide management decisions and future clinical trials for COVID-19 outpatients. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1938-2723 10760296 |
| العلاقة: | https://doaj.org/toc/1938-2723Test |
| DOI: | 10.1177/10760296221120421 |
| الوصول الحر: | https://doaj.org/article/e763408b7d534e61adeac7384af2b8bbTest |
| رقم الانضمام: | edsdoj.763408b7d534e61adeac7384af2b8bb |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 19382723 10760296 |
|---|---|
| DOI: | 10.1177/10760296221120421 |